2018 Chronic Pain Data Epilepsy 
MedicalJane
JUNE 12, 2020
A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes.
Veriheal
MAY 31, 2022
According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. For too long, America has relied too heavily on opioids for pain relief. A Better Alternative for Chronic Pain. The Opioid Problem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
DECEMBER 28, 2021
This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Chronic pain. It is because of the dedication of advocates and scientists that the medical cannabis industry is expected to generate a compound annual growth rate (CAGR) of 1 8.4% Alzheimer’s.
Otherside Farms
FEBRUARY 14, 2019
billion by 2020; the World Anti-Doping Agency eliminated the CBD from its list of banned substances; The Food and Drug Administration (FDA) for the first time approved a drug for epilepsy that contained CBD oil, prompting the US Drug Enforcement Administration to change its position about the CBD. The 2018 Farm Bill. What is CBD?
Veriheal
OCTOBER 5, 2020
Hawaii legalized cannabis in its’ House Bill 2729 which was passed in 2018. According to data from another American state, Colorado, cannabis edibles account for as much as 45% of all cannabis sales – which excludes those home-made edibles made from bought or grown cannabis bud (the flower we consume).
Veriheal
AUGUST 31, 2020
Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay Summary: Jack outlines the Hemp Farming Act, passed in December of 2018, and the implications of the bill for hemp companies and farmers.
Cannabis Law Report
OCTOBER 26, 2021
The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. 1 Data published by Research and Markets, March 2018. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases and COVID-19- associated depression. 646) 421-9523.
Expert insights. Personalized for you.
145 
Let's personalize your content